Skip to main navigation Skip to search Skip to main content

Department of Health Review of Life Savings Drugs Program medicines Mucopolysaccharidosis Type I (MPS I) Final Review Protocol

  • Stathis, S. (Advisor)
  • Lisa Fodero (Advisor)
  • Michael Ortiz (Advisor)
  • Justine Biggs (Advisor)
  • Nerissa Soh (Advisor)
  • Katrin Schultz (Advisor)

    Activity: End user engagement and expertiseAdvisory position